Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RORA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | ELF2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | SAXO1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | LIN37 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | VPS36 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | NDUFAF3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | GJB2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | UBE2T | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ACOT6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |